SG Americas Securities
PHIO icon

SG Americas Securities’s Phio Pharmaceuticals PHIO Stock Holding History

SG Americas Securities’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-133
Closed -$135K – 3628
2019
Q4 		$135K Buy
133
+14
+12% +$16.1K ﹤0.01% 2765
2019
Q3 		$194K Buy
119
+17
+17% +$35.6K ﹤0.01% 2371
2019
Q2 		$229K Buy
102
+63
+162% +$165K ﹤0.01% 2338
2019
Q1 		$103K Buy
39
+11
+39% +$24.7K ﹤0.01% 3052
2018
Q4 		$54K Hold
28
– – ﹤0.01% 2815
2018
Q3 		$192K Buy
28
+8
+40% +$75.3K ﹤0.01% 2584
2018
Q2 		$228K Buy
+20
New +$296K ﹤0.01% 2514

Other funds holding PHIO

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities's PHIO Position: Q1 2020 in Review

SG Americas Securities sold out of Phio Pharmaceuticals (PHIO) in Q1 2020, closing a stake of 133 shares — an estimated $135K sold.

SG Americas Securities first reported a position in PHIO in Q2 2018 and held it in 7 quarters. The position peaked at $229K in Q2 2019. 8 funds tracked by Wall St. Rank hold PHIO as of Q1 2020.

  • SG Americas Securities reported no remaining Phio Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • SG Americas Securities sold 133 Phio Pharmaceuticals shares in Q1 2020, an estimated $135K.
  • SG Americas Securities first reported a position in Phio Pharmaceuticals in Q2 2018 and held it in 7 quarters.
  • SG Americas Securities's Phio Pharmaceuticals position peaked at $229K in Q2 2019.
  • 8 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q1 2020.

Based on SG Americas Securities's 13F filing for Q1 2020, filed 30 Apr 2020.